Condensed Consolidated Statement of Noncontrolling Interests and Equity - USD ($) $ in Thousands	Total	Redemption of Operating Partnership units for cash	Redemption of Operating Partnership units for cash Series B Units	Redemption Of Units For Common Stock Series A Units	Redemption Of Units For Common Stock Series D Units	Noncontrolling Interest - Preferred Operating Partnership	Noncontrolling Interest - Preferred Operating Partnership Redemption of Operating Partnership units for cash Series B Units	Noncontrolling Interest - Preferred Operating Partnership Redemption Of Units For Common Stock Series A Units	Noncontrolling Interest - Preferred Operating Partnership Redemption Of Units For Common Stock Series D Units	Noncontrolling Interest - Operating Partnership	Noncontrolling Interest - Operating Partnership Redemption of Operating Partnership units for cash	Noncontrolling Interest - Other	Common Stock	Common Stock Redemption Of Units For Common Stock Series A Units	Common Stock Redemption Of Units For Common Stock Series D Units	Additional Paid-in Capital	Additional Paid-in Capital Redemption of Operating Partnership units for cash	Additional Paid-in Capital Redemption Of Units For Common Stock Series A Units	Additional Paid-in Capital Redemption Of Units For Common Stock Series D Units	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Balance, beginning of period at Dec. 31, 2021	$ 3,785,976					$ 259,110				$ 410,053		$ 317	$ 1,339			$ 3,285,948				$ (42,546)	$ (128,245)
Balance, beginning of period (in shares) at Dec. 31, 2021													133,922,305
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock in connection with share based compensation (in shares)													142,784
Issuance of common stock in connection with share based compensation	4,544												$ 2			4,542
Restricted stock grants cancelled (in shares)													(779)
Redemption of operating partnership units		$ (2,672)	$ (3,375)				$ (3,375)				$ (829)						$ (1,843)
Issuance of common stock in conjunction with acquisitions (in shares)													186,766
Issuance of common stock in conjunction with acquisitions	40,963												$ 2			40,961
Net income	217,717					4,333				9,805											203,579
Other comprehensive income	51,649					313				2,333										49,003
Distributions to Operating Partnership units held by noncontrolling interests	(14,111)					(4,330)				(9,781)
Dividends paid on common stock	(202,527)																				(202,527)
Balance, end of period at Mar. 31, 2022	3,878,164					256,051				411,581		317	$ 1,343			3,329,608				6,457	(127,193)
Balance, end of period (in shares) at Mar. 31, 2022													134,251,076
Balance, beginning of period at Dec. 31, 2022	$ 4,078,274					261,502				556,095		1,080	$ 1,339			3,345,332				48,798	(135,872)
Balance, beginning of period (in shares) at Dec. 31, 2022	133,921,020												133,921,020
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock in connection with share based compensation (in shares)													89,564
Issuance of common stock in connection with share based compensation	$ 5,499												$ 1			5,498
Taxes paid upon settlement of share based compensation (in shares)													(7,087)
Taxes paid upon net settlement of share based compensation	(7,449)															(7,449)
Restricted stock grants cancelled (in shares)													(2,222)
Redemption of operating partnership units				$ (5,316)	$ 0			$ (16,339)	$ (22,064)					$ 8	$ 2			$ 11,015	$ 22,062
Redemption of Operating Partnership units (in shares)														851,698	154,307
Noncontrolling interest in consolidated joint venture	1,391											1,391
Net income	208,878					2,254				10,378		(58)									196,304
Other comprehensive income	(14,510)									(793)										(13,717)
Distributions to Operating Partnership units held by noncontrolling interests	(14,078)					(2,413)				(11,665)
Dividends paid on common stock	(219,988)																				(219,988)
Balance, end of period at Mar. 31, 2023	$ 4,032,701					$ 222,940				$ 554,015		$ 2,413	$ 1,350			$ 3,376,458				$ 35,081	$ (159,556)
Balance, end of period (in shares) at Mar. 31, 2023	135,007,280												135,007,280